[1] Pickering TG, Davidson K, Gerin W, et al.Masked hypertension[J]. Hypertension,2002,40(6):795-796.
[2] Sega R, Trocino G, Lanzarotti A, et al.Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study)[J]. Circulation,2001,104(12):1385-1392.
[3] Redmond N, Booth JN 3rd, Tanner RM, et al. Prevalence of masked hypertension and its association with subclinical cardiovascular disease in African Americans: Results from the Jackson Heart Study[J]. J Am Heart Assoc,2016, 5(3):e002284.
[4] Hänninen MR, Niiranen TJ, Puukka PJ, et al.Target organ damage and masked hypertension in the general po-pulation: the Finn-Home study[J]. J Hypertens,2013,31(6):1136-1143.
[5] Komori T, Eguchi K, Kabutoya T, et al.Left ventricular diastolic function evaluated by the E/e' ratio is impaired in patients with masked uncontrolled hypertension[J]. Clin Exp Hypertens,2014,36(8):538-544.
[6] Caliskan M, Ciftci O, Gullu H, et al.Effect of masked, white-coat, and sustained hypertension on coronary flow reserve and peripheral endothelial functions[J]. Clin Exp Hypertens,2013,35(3):183-191.
[7] Manios E, Michas F, Tsivgoulis G, et al.Impact of prehypertension on carotid artery intima-media thickening: actual or masked?[J]. Atherosclerosis,2011,214(1):215-219.
[8] Manios E, Michas F, Stamatelopoulos K, et al.Association of isolated systolic, isolated diastolic, and systolic-diastolic masked hypertension with carotid artery intima-media thickness[J]. J Clin Hypertens (Greenwich),2015, 17(1):22-26.
[9] Drawz PE, Alper AB, Anderson AH, et al.Masked hypertension and elevated nighttime blood pressure in CKD: prevalence and association with target organ damage[J]. Clin J Am Soc Nephrol,2016,11(4):642-652.
[10] Kanno A, Metoki H, Kikuya M, et al.Usefulness of assessing masked and white-coat hypertension by ambulatory blood pressure monitoring for determining prevalent risk of chronic kidney disease: the Ohasama study[J]. Hypertens Res,2010,33(11):1192-1198.
[11] Björklund K, Lind L, Zethelius B, et al.Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men[J]. Circulation,2003,107(9):1297-1302.
[12] Mancia G, Facchetti R, Bombelli M, et al.Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure[J]. Hypertension,2006,47(5):846-853.
[13] Ohkubo T, Kikuya M, Metoki H, et al.Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study[J]. J Am Coll Cardiol,2005,46(3):508-515.
[14] Hansen TW, Kikuya M, Thijs L, et al.Prognostic superio-rity of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7,030 individuals[J]. J Hypertens,2007,25(8):1554-1564.
[15] Stergiou GS, Asayama K, Thijs L, et al.Prognosis of white-coat and masked hypertension: International Database of Home blood pressure in relation to Cardiovascular Outcome[J]. Hypertension,2014,63(4):675-682.
[16] Wang GL, Li Y, Staessen JA, et al.Anthropometric and lifestyle factors associated with white-coat, masked and sustained hypertension in a Chinese population[J]. J Hypertens,2007,25(12):2398-2405.
[17] Sivén SS, Niiranen TJ, Kantola IM, et al.White-coat and masked hypertension as risk factors for progression to sustained hypertension: the Finn-Home study[J]. J Hypertens,2016,34(1):54-60.
[18] Hara A, Ohkubo T, Kikuya M, et al.Detection of carotid atherosclerosis in individuals with masked hypertension and white-coat hypertension by self-measured blood pressure at home: The ohasama study[J]. J Hypertens,2007, 25(2):321-327.
[19] Seki M, Inoue R, Ohkubo T, et al.Association of environmental tobacco smoke exposure with elevated home blood pressure in Japanese women: the Ohasama study[J]. J Hypertens,2010,28(9):1814-1820.
[20] Ohira T, Tanigawa T, Tabata M, et al.Effects of habitual alcohol intake on ambulatory blood pressure, heart rate, and its variability among Japanese men[J]. Hypertension,2009,53(1):13-19.
[21] Brguljan-Hitij J, Thijs L, Li Y, et al.Risk stratification by ambulatory blood pressure monitoring across JNC classes of conventional blood pressure[J]. Am J Hypertens,2014,27(7):956-965.
[22] Franklin SS, Thijs L, Li Y, et al.Masked hypertension in diabetes mellitus: treatment implications for clinical practice[J]. Hypertension,2013,61(5):964-971.
[23] Pogue V, Rahman M, Lipkowitz M, et al.Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney di-sease[J]. Hypertension,2009,53(1):20-27.
[24] Grassi G, Seravalle G, Trevano FQ, et al.Neurogenic abnormalities in masked hypertension[J]. Hypertension,2007,50(3):537-542.
[25] Zou J, Li Y, Yan CH, et al.Blood pressure in relation to interactions between sodium dietary intake and renal handling[J]. Hypertension,2013,62(4):719-725.
[26] Inan B, Ates I, Ozkayar N, et al.Are increased oxidative stress and asymmetric dimethylarginine levels associated with masked hypertension?[J]. Clin Exp Hypertens,2016,38(3):294-298.
[27] Taner A, Unlu A, Kayrak M, et al.The value of serum asymmetric dimethylarginine levels for the determination of masked hypertension in patients with diabetes mellitus[J]. Atherosclerosis,2013,228(2):432-437.
[28] 中国高血压联盟,中国医师协会高血压专业委员会血压测量与监测工作委员会. 动态血压监测临床应用中国专家共识[J]. 中华心血管病杂志,2015,23(8):727-730.
[29] 中国医师协会高血压专业委员会,中国高血压联盟,中华医学会心血管病学分会. 家庭血压监测中国专家共识[J]. 中华高血压杂志,2012,20(6):525-529.
[30] Zhang L, Li Y, Wei FF, et al.Strategies for classifying patients based on office, home, and ambulatory blood pressure measurement[J]. Hypertension,2015,65(6):1258-1265.
[31] Wei FF, Li Y, Zhang L, et al.Persistence of masked hypertension in Chinese patients[J]. Am J Hypertens,2016, 29(3):326-331.
[32] de la Sierra A, Vinyoles E, Banegas JR, et al. Short-term and long-term reproducibility of hypertension phenotypes obtained by office and ambulatory blood pressure measurements[J]. J Clin Hypertens (Greenwich),2016,18(9):927-933.
[33] Trudel X, Milot A, Brisson C.Persistence and progression of masked hypertension: a 5-year prospective study[J]. Int J Hypertens,2013,2013:836387.
[34] Mancia G, Fagard R, Narkiewicz K, et al.2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension(ESH) and of the European Society of Cardiology(ESC)[J]. Eur Heart J,2013,34(28):2159-2219.
[35] Julius S, Nesbitt SD, Egan BM, et al.Feasibility of trea-ting prehypertension with an angiotensin-receptor blocker[J]. N Engl J Med,2006,354(16):1685-1697.
[36] Schrier RW, Estacio RO, Esler A, et al.Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes[J]. Kidney Int,2002,61(3):1086-1097.
[37] Verdecchia P, Reboldi G, Porcellati C, et al.Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects[J]. J Am Coll Cardiol,2002,39(5):878-885.
